title: Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding.
abstract: Ligand binding is a vital component of any pharmacologist's toolbox and allows the detailed investigation of how a molecule binds to its receptor. These studies enable the experimental determination of binding affinity of labelled and unlabelled compounds through kinetic, saturation (Kd ) and competition (Ki ) binding assays. Traditionally, these studies have used molecules labelled with radioisotopes; however, more recently, fluorescent ligands have been developed for this purpose. This review will briefly cover receptor ligand binding theory and then discuss the use of fluorescent ligands with some of the different technologies currently employed to examine ligand binding. Fluorescent ligands can be used for direct measurement of receptor-associated fluorescence using confocal microscopy and flow cytometry as well as in assays such as fluorescence polarization, where ligand binding is monitored by changes in the free rotation when a fluorescent ligand is bound to a receptor. Additionally, fluorescent ligands can act as donors or acceptors for fluorescence resonance energy transfer (FRET) with the development of assays based on FRET and time-resolved FRET (TR-FRET). Finally, we have recently developed a novel bioluminescence resonance energy transfer (BRET) ligand binding assay utilizing a small (19 kDa), super-bright luciferase subunit (NanoLuc) from a deep sea shrimp. In combination with fluorescent ligands, measurement of RET now provides an array of methodologies to study ligand binding. While each method has its own advantages and drawbacks, binding studies using fluorescent ligands are now a viable alternative to the use of radioligands. Linked Articles This article is part of a themed section on Molecular Pharmacology of G Protein-Coupled Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.20/issuetoc.
authors: Cell Signalling Research Group, School of Life Sciences, University of Nottingham, Nottingham, UK.
authors: Leigh A
authors: LA
authors: Stoddart
authors: Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research, Nedlands, WA, Australia.|Centre for Medical Research, The University of Western Australia, Crawley, WA, Australia.
authors: Carl W
authors: CW
authors: White
authors: Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research, Nedlands, WA, Australia.|Centre for Medical Research, The University of Western Australia, Crawley, WA, Australia.
authors: Kim
authors: K
authors: Nguyen
authors: Cell Signalling Research Group, School of Life Sciences, University of Nottingham, Nottingham, UK.|Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research, Nedlands, WA, Australia.|Centre for Medical Research, The University of Western Australia, Crawley, WA, Australia.
authors: Stephen J
authors: SJ
authors: Hill
authors: Molecular Endocrinology and Pharmacology, Harry Perkins Institute of Medical Research, Nedlands, WA, Australia. kevin.pfleger@perkins.uwa.edu.au.|Centre for Medical Research, The University of Western Australia, Crawley, WA, Australia. kevin.pfleger@perkins.uwa.edu.au.
authors: Kevin D G
authors: KD
authors: Pfleger
mesh_terms: D001665:Binding Sites / Q000187:drug effects; D005453:Fluorescence; D031541:Fluorescence Resonance Energy Transfer; D005456:Fluorescent Dyes / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008024:Ligands; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D005456:Fluorescent Dyes; D008024:Ligands; D043562:Receptors, G-Protein-Coupled